Literature DB >> 19138989

Multiple aberrations of chromosome 3p detected in oral premalignant lesions.

Ivy F L Tsui1, Miriam P Rosin, Lewei Zhang, Raymond T Ng, Wan L Lam.   

Abstract

The study of oral premalignant lesions (OPL) is crucial to the identification of initiating genetic events in oral cancer. However, these lesions are minute in size, making it a challenge to recover sufficient DNA from microdissected cells for comprehensive genomic analysis. As a step toward identifying genetic aberrations associated with oral cancer progression, we used tiling-path array comparative genomic hybridization to compare alterations on chromosome 3p for 71 OPLs against 23 oral squamous cell carcinomas. 3p was chosen because although it is frequently altered in oral cancers and has been associated with progression risk, its alteration status has only been evaluated at a small number of loci in OPLs. We identified six recurrent losses in this region that were shared between high-grade dysplasias and oral squamous cell carcinomas, including a 2.89-Mbp deletion spanning the FHIT gene (previously implicated in oral cancer progression). When the alteration status for these six regions was examined in 24 low-grade dysplasias with known progression outcome, we observed that they occurred at a significantly higher frequency in low-grade dysplasias that later progressed to later-stage disease (P < 0.003). Moreover, parallel analysis of all profiled tissues showed that the extent of overall genomic alteration at 3p increased with histologic stage. This first high-resolution analysis of chromosome arm 3p in OPLs represents a significant step toward predicting progression risk in early preinvasive disease and provides a keen example of how genomic instability escalates with progression to invasive cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19138989      PMCID: PMC2744606          DOI: 10.1158/1940-6207.CAPR-08-0123

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  36 in total

1.  Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients.

Authors:  Suman Bhusan Chakraborty; Santanu Dasgupta; Anup Roy; Arunava Sengupta; Bidyut Ray; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Cancer Genet Cytogenet       Date:  2003-10-15

2.  Breakpoint identification and smoothing of array comparative genomic hybridization data.

Authors:  Kees Jong; Elena Marchiori; Gerrit Meijer; A V D Vaart; Bauke Ylstra
Journal:  Bioinformatics       Date:  2004-06-16       Impact factor: 6.937

3.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.

Authors:  Antoine M Snijders; Brian L Schmidt; Jane Fridlyand; Nusi Dekker; Daniel Pinkel; Richard C K Jordan; Donna G Albertson
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

Review 4.  Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

5.  Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.

Authors:  Shiladitya Sengupta; Susmita Chakrabarti; Anup Roy; Chinmay K Panda; Susanta Roychoudhury
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

6.  Multiple microalterations detected at high frequency in oral cancer.

Authors:  Corisande Baldwin; Cathie Garnis; Lewei Zhang; Miriam P Rosin; Wan L Lam
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

7.  A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization.

Authors:  M Partridge; S Pateromichelakis; E Phillips; G G Emilion; R P A'Hern; J D Langdon
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

8.  Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.

Authors:  Laura J Rush; Aparna Raval; Pauline Funchain; Amy J Johnson; Lisa Smith; David M Lucas; Melania Bembea; Te-Hui Liu; Nyla A Heerema; Laura Rassenti; Sandya Liyanarachchi; Ramana Davuluri; John C Byrd; Christoph Plass
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.

Authors:  Vladimir I Kashuba; Jingfeng Li; Fuli Wang; Vera N Senchenko; Alexey Protopopov; Alena Malyukova; Alexey S Kutsenko; Elena Kadyrova; Veronika I Zabarovska; Olga V Muravenko; Alexander V Zelenin; Lev L Kisselev; Igor Kuzmin; John D Minna; Gösta Winberg; Ingemar Ernberg; Eleonora Braga; Michael I Lerman; George Klein; Eugene R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

10.  Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas.

Authors:  Cathie Garnis; Corisande Baldwin; Lewei Zhang; Miriam P Rosin; Wan L Lam
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  16 in total

1.  Chromosomal imbalances exclusively detected in invasive front area are associated with poor outcome in laryngeal carcinomas from different anatomical sites.

Authors:  Eliane Papa Ambrosio; Cássia Gisele Terrassani Silveira; Sandra Aparecida Drigo; Vivian de Souza Sacomano; Miriam Coelho Molck; Rafael Malagoli Rocha; Maria Aparecida Custódio Domingues; Fernando Augusto Soares; Luiz Paulo Kowalski; Silvia Regina Rogatto
Journal:  Tumour Biol       Date:  2013-06-08

2.  The identification of significant chromosomal regions correlated with oral tongue cancer progression.

Authors:  Ki-Yeol Kim; In-Ho Cha
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-26       Impact factor: 4.553

3.  Integrative molecular characterization of head and neck cancer cell model genomes.

Authors:  Ivy F L Tsui; Cathie Garnis
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

4.  Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Authors:  Ivy F L Tsui; Catherine F Poh; Cathie Garnis; Miriam P Rosin; Lewei Zhang; Wan L Lam
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

5.  Validation of LOH profiles for assessing oral cancer risk.

Authors:  Mark W Lingen; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2012-08-21

6.  A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.

Authors:  Ivy F L Tsui; Cathie Garnis; Catherine F Poh
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

7.  Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma.

Authors:  L K Ng; A M Rich; H M Hussaini; W M Thomson; A L Fisher; L S Horne; G J Seymour
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

8.  Deciphering squamous cell carcinoma using multidimensional genomic approaches.

Authors:  Ewan A Gibb; Katey S S Enfield; Ivy F L Tsui; Raj Chari; Stephen Lam; Carlos E Alvarez; Wan L Lam
Journal:  J Skin Cancer       Date:  2010-12-27

9.  Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation.

Authors:  Alejandra B Ochoa-Hernández; Moisés Ramos-Solano; Ivan D Meza-Canales; Beatriz García-Castro; Mónica A Rosales-Reynoso; Judith A Rosales-Aviña; Esperanza Barrera-Chairez; Pablo C Ortíz-Lazareno; Georgina Hernández-Flores; Alejandro Bravo-Cuellar; Luis F Jave-Suarez; Patricio Barros-Núñez; Adriana Aguilar-Lemarroy
Journal:  BMC Cancer       Date:  2012-02-07       Impact factor: 4.430

10.  Genomic imbalances in precancerous tissues signal oral cancer risk.

Authors:  Cathie Garnis; Raj Chari; Timon P H Buys; Lewei Zhang; Raymond T Ng; Miriam P Rosin; Wan L Lam
Journal:  Mol Cancer       Date:  2009-07-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.